Gene therapy
UK approves world-first gene-editing treatment for blood disorders
The UK has become the first country in the world to approve a gene therapy as a potential cure for two inherited blood disorders.
Stories tagged with 'Drug discovery'
AI health innovators
New £28m Centre to forge the next generation of AI digital healthcare innovators
A new £28 million UKRI AI Centre for Doctoral Training at Imperial College London will train over 120 researchers to develop patient-ready technology.
1
Quantum drug discovery
Towards using quantum computing to speed up drug development
Researchers have developed a quantum processor that can perform crucial drug design methods, which could lead to more efficient drug development.
1
WATER MECHANISM IN CELLS
New mechanism found that maintains water balance within cells
Scientists have discovered a new mechanism that allows cells to maintain their ideal water availability from second to second.
Medical innovation
Imperial President - College making big moves to accelerate medical innovation
Professor Hugh Brady says that Imperial is working to speed development of innovations that have potential to be as transformational as penicillin.
Translation boost
Apollo Therapeutics raises $226.5m to develop medicines based on uni research
Company founded by the tech transfer offices of Imperial, Cambridge and UCL has raised major Series C funding to turn basic research into medicines.
To glow brightly
Nobel-winning bodily ‘pressure sensors’ filmed for first time at Imperial
Imperial researchers have filmed, for the first time, bodily ‘pressure sensors’ whose discoverers won the 2021 Nobel Prize in Physiology or Medicine.
Database of drug targets
New database of drug targets will help fight incurable diseases
Researchers have produced a database and new analysis platform which could help transform drug development for difficult-to-drug diseases
Analytical science
Imperial and Agilent renew partnership for flagship analytical science facility
Imperial and Agilent Technologies have announced the extension of their partnership to support advanced analytical science.
Prosperity partnership
New partnership will use molecular glues to tackle ‘undruggable’ disease targets
Researchers at Imperial, the Francis Crick Institute and AstraZeneca will advance the discovery of new ‘molecular glues’ to treat a range of diseases.
